Copyright © 2024 Research Nester. All Rights Reserved
West Syndrome Market size was over USD 1.05 Billion in 2023 and is likely to reach USD 2.03 Billion by the end of 2036, witnessing around 5.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of west syndrome is assessed at USD 1.1 Billion. The growth of the market can be attributed to the rising prevalence of epilepsy. The World Health Organization (WHO) provided a report stating that nearly 5 million individuals are diagnosed with epilepsy every year worldwide. Epilepsy is one of the most common chronic disorders across the world. It is a non-communicable disease that affects the central nervous system and causes physical impairment of the body. The recurrent seizures cause discomfort in movement eventually leading to paralysis. It is mainly caused by brain damage, head injury, absence of oxygen, brain infection, brain tumor, meningitis, encephalitis, and neurocysticercosis.
Global west syndrome market trends such as growing awareness of west syndrome in the global population and rising healthcare expenditure are projected to influence the growth of the market positively over the forecast period. In a report published by the World Bank, it was stated that in 2019, the healthcare expenditure reached 1,121.9 per capita. West syndrome is a serious medical condition with a drastically irregular pattern of brain waves which is also known as hypsarrhythmia. West syndrome also includes features such as infantile spasms and loss of developmental milestones. Moreover, spiking R&D spending on neurological illnesses and the rising inclination of the global population toward novel therapies are further anticipated to propel the growth of the market over the forecast period.
Growth Drivers
Growing Incidence of Traumatic Brain Injuries to Boost the Market Growth - As of 2019, around 200,000 people were noticed to be hospitalized while nearly 62,000 people died due to traumatic brain injuries in the same year in United States. Traumatic brain injury, shortly known as TBI can affect the functionality of the brain in multiple ways. It is categorized into two categories that are closed and penetrating brain injury. TBI can also cause death and serious disabilities becoming the major cause of death in the United States. Hence, such a higher prevalence is estimated to hike the market growth over the forecast period.
Higher Prevalence of Drug Seizure - In 2022-21, about 5500 drug seizures per million inhabitants were observed solely in London.
Significant Growth in the Imaging Technology - For instance, the diagnostic imaging devices segment was valued at nearly USD 45 billion in 2022 worldwide.
Growing Penetration of Neurological Disorders - Based on the data released by Pan American Health Organization (PAHO), in 2019, about 533,172 people died due to neurological conditions in the United States.
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
5.2% |
|
Base Year Market Size (2023) |
USD 1.05 Billion |
|
Forecast Year Market Size (2036) |
USD 2.03 Billion |
|
Regional Scope |
|
Product Type {Solid Dosage (Tablet, Capsule), Liquid Dosage (Injectable)}
The global west syndrome market is segmented and analyzed for demand and supply by product type into solid dosage (tablet and capsule), and liquid dosage (injectable and others), out of which, the solid dosage segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising consumption of medicine across the globe. For instance, in 2021, global medicine spending was estimated to be nearly USD 1 trillion. The increasing health issues faced by people every day owing to rising chemical food, and an improper nutrient diet leads to suppressed immunity in young and adults. The increasing population of adults across the globe with growing longevity and early diagnosis of diseases is estimated to boost the market growth during the forecast period. The increasing occurrence of chronic diseases such as diabetes, cancer, blood pressure, and cholesterol require lifelong medications for proper regulation and prevention of further complications.
Distribution Channel (Retail, Online, Hospitals)
The global west syndrome market is also segmented and analyzed for demand and supply by distribution channel into retail, online, and hospitals. Amongst these three segments, the hospitals segment is expected to garner a significant share. Hospitals are the place where more patients come for chronic and serious disease treatment. The increasing number of chronic diseases worldwide is estimated to boost the growth of the market during the forecast period. According to the Centers for Disease Control and Prevention, 6 members out of 10 in the U.S. are suffering from chronic disease. The increasing healthcare sector is expanding with a growing number of diseases that are contagious such as COVID-19. West syndrome is a disorder of brain function that can cause impairment of body parts. Epilepsy and seizures are the side effects of west syndrome which need complete nervous treatment. The increasing disposable income and rising awareness of people are estimated to increase the growth of hospitals which in turn increases the market growth during the forecast period.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Administration Route |
|
|
By Treatment |
|
|
By Distribution Channel |
|
|
By End-User |
|
North American Market Forecast
The North American west syndrome market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the escalation in the number of people living with traumatic brain injuries. For instance, in 2020, more than 60,000 people lost their lives due to traumatic brain injuries solely in the USA while approximately 150 death occurs on a daily basis in the same region. The increasing number of accidents on road cause brain damage or brain injury. The growing number of brain surgeries owing to infection, cancer, or side effect of any disease are estimated to rise market growth. Accidents in sports are also rising owing to the increasing preference of people for fitness and physical activity. Brain diseases can also be caused by genetic disorders that occur during birth.
APAC Market Statistics
Moreover, the second largest market share is occupied by the Asia Pacific region. The growth of the market is attributed to the increasing prevalence of diseases, improvement in the healthcare sector, and growing awareness of treatment among people. The rising healthcare infrastructure and facilities in the countries of the Asia Pacific region including China and India play a major role in the market growth. As per the research, it is reported that the healthcare expenditure of China in 2020 was estimated to be USD 1 trillion
Eisai Co., Ltd. to announce its first presentation with Merck & Co., Inc. associated with the Phase 3 LEAP-002 trial investigating LENVIMA, a receptor tyrosine, orally available and discovered by Eisai. Furthermore, the anti-PD-1 therapy, plus KEYTRUSA, from Merck & Co., Inc., is also introduced as a first-line treatment for uHCC.
SK Biopharmaceuticals Co., Ltd. to announce the result of the long-term randomized open-label extension (OLE). The company is focused on treatment development for central nervous system (CNS) disorders. Data analyzed in the OLE phase was taken from nearly 335 adult patients having focal seizures. from nearly 355 adult patients having focal seizures.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?